Fig. 4: Progression-free survival. | Nature Communications

Fig. 4: Progression-free survival.

From: Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

Fig. 4: Progression-free survival.

A Kaplan-Meier curve of response duration stratified by 20/2/20 risk groups. B Kaplan-Meier curve of progression stratified by 20/2/20 risk groups. Survival distributions were compared using two-sided log-rank tests. Outcomes stratified by the presence of evolving disease prior to treatment. C Overall survival D Biochemical progression-free survival E Time-to-progression and F Duration of response. NR not reached. Survival distributions were compared using two-sided log-rank tests. Source data are provided as a Source Data file.

Back to article page